2nd Quarter - Report

PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

Firm
Client
Income
—
Expenses
$1,601,681
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 S.464 / H.R.2163: Safe Step Act S.917: Short on Competition Act H.R.2355: Opioid Prescription Verification Act H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2843: STOP GAMES Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2853: BLOCKING Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1425 / H.R.2883: Stop STALLING Act S.1427 / H.R.2869: Increasing Access to Biosimilars Act S.1428 / H.R.2891: Preserve Access to Affordable Generics and Biosimilars Act S.1435 / H.R.2873: Affordable Prescriptions for Patients Act / Affordable Prescriptions for Patients Through Promoting Competition Act H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S.1462: Simplifying the Generic Drug Application Process Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524: Health Care PRICE Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs More Cures Act H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees

LobbyistCovered position, as disclosed
KRISTIN A BASS —
GLEN RANDALL CHAMBERS New Chief of Staff, Sen. Republican Conf. Vice Chair; Chief of Staff, Sen. Roy Blunt; Chief of Staff, Sen. Sam Brownback; Leg. Director, Sen. Brownback; Leg. Asst., Sen. Brownback; Correspondence Dir., Sen. Brownback; Leg. Correspondent, Sen. Brownback
JONATHAN M HEAFITZ —
KATHERINE C. MURPHY —
JUAN CARLOS SCOTT —
JOCELYN WILES —

Contacted: SENATE; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 2843 (117th), S. 1462 (117th), S. 1435 (117th), H.R. 2883 (117th), S. 1463 (117th), H.R. 4158 (117th), H.R. 3554 (117th), S. 298 (117th), H.R. 3173 (117th), H.R. 1829 (117th), S. 2164 (117th), H.R. 2410 (117th), S. 1909 (117th), H.R. 2484 (117th), H.R. 2608 (117th), H.R. 2853 (117th), H.R. 2846 (117th), H.R. 3 (117th), S. 1524 (117th), H.R. 2163 (117th), S. 1427 (117th), S. 917 (117th), S. 1425 (117th), H.R. 2891 (117th), H.R. 2855 (117th), H.R. 19 (117th), H.R. 4121 (117th), S. 464 (117th), H.R. 2884 (117th), H.R. 2869 (117th), H.R. 2873 (117th), H.R. 3682 (117th), S. 1388 (117th), H.R. 2355 (117th), S. 1523 (117th), S. 1428 (117th)

Postal POS

Issues related to the use of the United States Postal Service (USPS) for prescription drug home delivery S.1720 / H.R.3076: The Postal Service Reform Act of 2021

LobbyistCovered position, as disclosed
JONATHAN M HEAFITZ —

Contacted: Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Bills named: H.R. 3076 (117th), S. 1720 (117th)

Medicare/Medicaid MMM

Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2410: Medicare and You Handbook Improvement Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.2855: Star Ratings for Biosimilars Act S.1523: The Drug Price Transparency Act H.R.3173: Improving Seniors Timely Access to Care Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.3682: Improving Transparency to Lower Drug Costs Act S.2164: Lower Costs, More Cures Act of 2021 H.R.4121: To codify a final rule issued by the Secretary of Health and Human Services relating to fraud and abuse and the removal of safe harbor protection for certain drug rebates, and for other purposes H.R.4158: To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees

LobbyistCovered position, as disclosed
KRISTIN A BASS —
GLEN RANDALL CHAMBERS New Chief of Staff, Sen. Republican Conf. Vice Chair; Chief of Staff, Sen. Roy Blunt; Chief of Staff, Sen. Sam Brownback; Leg. Director, Sen. Brownback; Leg. Asst., Sen. Brownback; Correspondence Dir., Sen. Brownback; Leg. Correspondent, Sen. Brownback
JONATHAN M HEAFITZ —
KATHERINE C. MURPHY —
JUAN CARLOS SCOTT —
JOCELYN WILES —

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 19 (117th), H.R. 3554 (117th), H.R. 3173 (117th), H.R. 4121 (117th), S. 1909 (117th), H.R. 2855 (117th), H.R. 2608 (117th), H.R. 3682 (117th), H.R. 3 (117th), H.R. 2846 (117th), H.R. 1829 (117th), H.R. 4158 (117th), H.R. 2410 (117th), S. 1523 (117th), H.R. 2484 (117th), S. 2164 (117th), S. 298 (117th)

Pharmacy PHA

Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, direct and indirect remuneration (DIR), pharmacy networks, and mail-service pharmacy Access to prescription drugs during the coronavirus pandemic S.298 / H.R.1829: Pharmacy Benefit Manager Accountability Study Act of 2021 H.R.2355: Opioid Prescription Verification Act H.R.2484: Lowest Price for Patients Act H.R.2608: Ensuring Seniors Access to Local Pharmacies Act H.R.3: Elijah E. Cummings Lower Drug Costs Now Act H.R.19: Lower Costs, More Cures Act H.R.2855: Star Ratings for Biosimilars Act S.1388: Prescription Pricing for the People Act S.1463: Modernizing Therapeutic Equivalence Rating Determination Act S.1523: The Drug Price Transparency Act S.1524: Health Care PRICE Transparency Act S.1909 / H.R.3554: Pharmacy DIR Reform to Reduce Senior Drug Costs Act S.2164: Lower Costs More Cures Act 42 CFR Part 1001 RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees

LobbyistCovered position, as disclosed
KRISTIN A BASS —
GLEN RANDALL CHAMBERS New Chief of Staff, Sen. Republican Conf. Vice Chair; Chief of Staff, Sen. Roy Blunt; Chief of Staff, Sen. Sam Brownback; Leg. Director, Sen. Brownback; Leg. Asst., Sen. Brownback; Correspondence Dir., Sen. Brownback; Leg. Correspondent, Sen. Brownback
JONATHAN M HEAFITZ —
KATHERINE C. MURPHY —
JUAN CARLOS SCOTT —
JOCELYN WILES —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2355 (117th), S. 1909 (117th), H.R. 2608 (117th), H.R. 3 (117th), H.R. 1829 (117th), S. 1463 (117th), S. 1523 (117th), H.R. 2855 (117th), S. 298 (117th), S. 1388 (117th), S. 2164 (117th), S. 1524 (117th), H.R. 19 (117th), H.R. 2484 (117th), H.R. 3554 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.